Comparing new PET scans for Parkinson's, MSA, Lewy body dementia, and Alzheimer's
Part of Brain & nervous system, Heart & circulation, Mental health clinical trials.
This study tests if a new radioactive tracer called [18F]-MFBG can help doctors better distinguish between Parkinson's disease, multiple system atrophy (MSA), dementia with Lewy bodies, and Alzheimer's disease. It compares the new scan with two standard scans to see which is most accurate.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 85 years old, or 45-85 if you have Parkinson's, MSA, or dementia.
- You must be able to undergo PET and MRI scans.
- You must not have major medical conditions like uncontrolled diabetes or heart disease.
- You must not be pregnant or breastfeeding.
- You must agree to avoid strenuous physical activity during the study.
- You must have a previous abnormal scan for certain conditions (Parkinson's, MSA, or Lewy body dementia).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a new ultra-high resolution PET scanner to look at brain changes in healthy aging, dementia, ALS, movement disorders, and psychosis. It aims to better understand these conditions and improve imaging techniques.
This study uses a new PET scan tracer called [11C]SY08 to take pictures of the brain in people with Parkinson's, multiple system atrophy, or dementia with Lewy bodies. It aims to see if this tracer can help better understand and tell apart these conditions.
This early-phase study tests a new PET scan tracer that targets a brain chemical transport system involved in dementia. It aims to see if the tracer can safely and clearly show brain changes, which could help future dementia diagnosis or tracking.
This research study tests a new type of brain scan (called a PET scan) that may help detect early signs of Parkinson's disease and similar conditions. You'll receive the scan and may have a spinal tap to check for specific protein markers.
This early-stage research trial tests a new brain-imaging tracer called [11C]MODAG-005 to help doctors better understand Parkinson's disease (PD) and multiple system atrophy (MSA). You would undergo PET/CT and MRI scans twice, a few weeks apart, to see how reliable the imaging is.
This study uses a special type of brain scan (PET/CT) to look at a protein called MAO-B in people with Parkinson's disease or related conditions. The scan may help doctors understand more about the disease and could be part of your regular care.
Hear when a new Dementia With Lewy Bodies trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.